Table 3 Clinicopathological characteristics of the samples with concurrent mutations in the four genomic subtypes.

From: Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel

No.

Gender

Age

Breslow (mm)

Anatomic site

Sun related site

Histological subtype

Gene

Amino acid change

Allele frequency (%)

2

M

79

2.7

Trunk

Occasional exposed

SSM

BRAF

p.Gly464Arg

6.8

NF1

p.Arg711Cys

4.7

28

F

58

0.7

Lower extremities

Occasional exposed

SSM

NRAS

p.Glu62Gln

8.0

NRAS

p.Gln61Arg

8.0

58

M

69

0.4

Trunk

Occasional exposed

SSM

BRAF

p.Leu597Arg

4.1

NRAS

p.Gly12Ser

5.0

62

M

66

4.2

Head and neck

Usually exposed

LMM

KRAS

p.Gly12Val

80.8

NF1

p.Trp1512*

30.8

68

M

54

0.7

Head and neck

Usually exposed

SSM

BRAF

p.Val600Glu

25.4

NF1

p.Lys1844Th

6.3

71

F

85

3

Acral

Non exposed

ALM

KIT

p.Tyr553Ser

31.8

KIT

p.Tyr578Cys

43.9

80

F

73

0.3

Upper extremities

Occasional exposed

SSM

BRAF

p.Val600Glu

2.0

NRAS

p.Gln61Arg

3.0

84

F

57

2

Upper extremities

Occasional exposed

SSM

BRAF

p.Leu584Phe

23.1

NRAS

p.Gln61Leu

24.0

107

M

59

6

Head and neck

Usually exposed

NM

KRAS

p.Gln61Arg

5.3

KRAS

p.Ala146Val

10.6

NF1

p.Gln1070*

13.5

  1. M: Male; F: Female; SSM: Superficial spreading melanoma; LM: Lentigo Maligna; NM: Nodular melanoma; ALM: Acral lentiginous melanoma.